Welcome to our dedicated page for ES BANCSHARES (MD) news (Ticker: $ESBS), a resource for investors and traders seeking the latest updates and insights on ES BANCSHARES (MD) stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ES BANCSHARES (MD)'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ES BANCSHARES (MD)'s position in the market.
ES Bancshares, Inc. reported a net loss of $103 thousand for Q1 2024, compared to net income of $84 thousand for Q4 2023. The company reduced wholesale funding, grew average deposits by 3.4%, and saw a decrease in non-interest expenses by 8%. Net interest margin narrowed to 2.12%, and non-performing asset ratios remained favorable. Total assets decreased by 1.6%, total liabilities decreased by $10.4 million, and the company maintained strong capital ratios. The company did not repurchase shares in Q1 2024.
